Subclinical hypothyroidism - new cardiovascular risk factor


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In last years there is discussion about subcLinicaL hypothyroidism (SHT) as a cardiovascular risk factor. We examined 870 patients with coronary artery disease. Height, weight, body mass index, thyroid-stimulating hormone level, lipid profile, homocysteine level were assessed in all patients. The presence of a history of arterial hypertension, diabetes mellitus type 2, and conducted therapy were considered. Elevation of thyroid-stimulating hormone level (so called SHT) has been associated with obesity, diabetes mellitus type 2, arterial hypertension, atherogenic dystipidemia, hyperhomocysteinemia. Multiple coronary lesion significantly higher revealed in patients with SHT. SHT was additional independent risk factor for coronary atherosclerosis.

Full Text

Restricted Access

About the authors

Anna Ralfovna Volkova

Pavlov First Saint Petersburg state medical university

Email: volkovaa@mail.ru
PhD, associate professor of Department of faculty therapy

Svetlana Vladimirovna Dora

Pavlov First Saint Petersburg state medical university

PhD, assistant professor of Department of faculty therapy

Olga Alexandrovna Berkovich

Pavlov First Saint Petersburg state medical university

MD, professor, professor of Department of faculty therapy

Olga Dmitrievna Dygun

Pavlov First Saint Petersburg state medical university

resident of Department of faculty therapy

Yelena Vladimirovna Volkova

Pavlov First Saint Petersburg state medical university

PhD, associate professor of Department of faculty therapy

Yelena Nikolaevna Ostroukhova

Pavlov First Saint Petersburg state medical university

PhD, associate professor of Department of faculty therapy

References

  1. Rodondi N., Elzen W.P., Bauer D.C. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(1):1365-74.
  2. Duntas L. H., Brenta G. The effect of thyroid disorders on lipid levels and metabolism. Med. Clin. North. Am. 2012;96(2):269-81.
  3. Deicher R., Vierhapper H. Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? Thyroid. 2002;12(8):733-6.
  4. Петунина Н. А., Трухина Л.В. Гипотиреоз. Русский медицинский журнал. 2013; 12: 664-6. [Petunina N.A., Trukhina L.V. Hypothyroidism. RMJ. 2013;12:664-6. (in Russian)]
  5. Hernandez-Mijares A., Jover A., Bellod L., Banuls C., Sola E., Veses S., Victor V.M., Rocha M. Relation between lipoprotein subfractions and TSH levels in the cardiovascular risk among women with subclinical hypothyroidism. Clin. Endocrinol. 2013;78(5):777-82.
  6. Traub-Weidinger T., Graf S., Beheshti M., Ofluoglu S., Zettinig G., Khorsand A., Nekolla S.G., Kletter K., Dudczak R., Pirich C. Coronary vasoreactivity in subjects with thyroid autoimmunity and subclinical hypothyroidism before and after supplementation with thyroxine. Thyroid.2011;22(3):245-51.
  7. Duntas L. H., Biondi B. New insights into subclinical hypothyroidism and cardiovascular risk. Semin. Thromb. Hemost. 2011; 37(1): 27-34.
  8. Biondi B. Natural history, diagnosis and management of subclinical thyroid dysfunction. Best Pract. Res. Clin. Endocrinol. Metab. 2012;26(4):431-46.
  9. Hofman A., Darwish Murad S., van Duijn C.M., Franco O.H., Goedegebure A., Ikram M.A., Klaver C.C., Nijsten T.E., Peeters R.P., Stricker B.H., Tiemeier H.W., Uitterlinden A.G., Vernooij M.W. The Rotterdam Study: 2014 objectives and design update. Eur. J. Epidemiol. 2013; 28(111:889-926.
  10. Фадеев В.В. Современные принципы диагностики и лечения гипотиреоза. Медицинский совет. 2013; 4: 76-81. [Fadeyev V.V. Principles of diagnosis and treatment of hypothyroidism today. Medical council. 2013;4:76-81 (in Russian)]
  11. Baloch Z., Carayon P., Conte-Devolx B., Demers L.M., Feldt-Rasmussen U., Henry J.F., LiVosli V.A., Niccoli-Sire P., John R., Ruf J., Smyth P.P., Spencer C.A., Stockigt J.R. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1): 3-126.
  12. Некрасова Т.А., Стронгин Л.Г., Леденцова О.В., Казакова Л.В. Взаимосвязь между уровнем ТТГ и некоторыми факторами сердечно-сосудистого риска при аутоиммунном тиреоидите и субклиническом гипотиреозе. Клиническая и экспериментальная тиреоидология. 2014; 10 (2): 16-21. [Nekrasova T.A., Strongin L.G., Ledentsova O.V., Kasakova L.V. Relationship between TSH values and cardiovascular risk factors in patients with autoimmune thyroiditis and subclinical hypothyroidism. Clinical and experimental thyroidology. 2014;10(2):16-21 (in Russian)]
  13. Фадеев В.В. По материалам клинических рекомендаций Американской ассоциации клинических эндокринологов и Американской тиреоидной ассоциации по диагностике и лечению гипотиреоза у взрослых. Клиническая и экспериментальная тиреоидология. 2012;8(3):1-8. [Fadeev V.V. Clinical practice guidelines for hypothyroidism in adults: co-sponsored by American association of clinical endocrinologists and American thyroid association. Clinical and experimental thyroidology. 2012 ;8(3) :1 -8 (in Russian)]

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies